Pharmafile Logo

DOHM

DOHM is a full-service creative consultancy with over 20 years experience. We believe in developing long, strong working partnerships with our clients, helping them define and clarify their objectives, understand their brand audience and develop a creative style to work and integrate the brand communication. As a responsive team creating brand identity, pack design, NPD, design for print, design-led advertising and new media we have found that listening, and working in partnership with our clients has proved an effective way to create great work, a good reputation and happy clients.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Twelve Marketing

Twelve delivers healthcare communications that drive Change for Good. We support pharma and medtech clients with strategic marketing, behaviour-led campaigns, and purposeful PR, helping teams engage professionals and the public,…

View Profile

Wizzard

We are Wizzard: an independently owned, fully-integrated medical communications agency that is committed to crafting brilliant and engaging work. We work alongside you to cultivate a deep understanding of your…

View Profile

Company Details

2 Blake Mews, Kew, Richmond, TW9 3GA, United Kingdom
+44 (0)20 8439 9070

 Latest Content from PMHub 

MFN Pricing Is Moving Fast – Here’s What Matters

With GENEROUS, GUARD, and GLOBE all released since December, 185 pages of policy will materially impact U.S. drug pricing — and yes, it's a lot to digest. In a new...

ISPOR’s 2026–2027 HEOR Trends report: The Era of Evidence Judgment

In response to ISPOR’s recently published 2026-2027 HEOR Trends, David Miller, CEO, Genesis Research Group, suggests that we’re no longer being evaluated on our ability to produce data, but on...

First impressions matter: Why getting your onboarding right is key for digital engagement

Press Releases | January 20, 2026 | Graphite Digital

As pharma organisations invest extensively in creating engaging content, the onboarding process must not be overlooked. Seamless onboarding is the key to ensuring that HCPs not only meet regulatory standards,...

How can pharma build genuine partnerships with patient communities?

Patient engagement is not optional in pharma – it’s integral. Meaningful partnerships with patients, caregivers and advocates must shape every stage of healthcare and medicines development, driving better outcomes, equity...

How will AI change field training?

Press Releases | January 15, 2026 | Inizio

Learn how a next-generation approach to field training – powered by GenAI and avatar simulations and enabled through Intelligent Commercialization™ – can transform field force effectiveness by delivering scalable, always-on,...

The Heart and Mouth Connection Every Woman Needs to Know

For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at...

Inizio Ignite Sparks a New Era of Connected Advisory Solutions

Press Releases | January 7, 2026 | Inizio

Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, fully integrated advisory partner designed to accelerate pharma performance through strategy, insights, and innovation.

MM+M Podcast explores AI-powered audience intelligence with Inizio Evoke

Press Releases | January 7, 2026 | Inizio

The MM+M Podcast features a conversation with Jamie Avallone, Chief Data Officer at Inizio Evoke, and Iris Lin, Product Science Lead at Inizio Evoke, who share their perspectives on what...

Uncovering Inequities in Alzheimer’s Disease Screening and Care

  On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their...

Five Predictions That Will Reshape Biopharma Commercialisation in 2026

White Papers and Resources | January 5, 2026 | Nmblr

Every year, we’re met with restructuring, hiring freezes, and portfolio cuts. And every year we tell ourselves the same story. It’s a rough patch. A cycle that will reverse. But...